<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-2016-1-21-32</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-985</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>ФУНКЦИОНАЛЬНО-МЕТАБОЛИЧЕСКИЕ ОСОБЕННОСТИ ФАГОЦИТОВ КРОВИ ПРИ РАЗНЫХ ФОРМАХ ТУБЕРКУЛЕЗНОГО ВОСПАЛИТЕЛЬНОГО ПРОЦЕССА ЛЕГКИХ</article-title><trans-title-group xml:lang="en"><trans-title>FUNCTIONAL AND METABOLIC FEATURES OF BLOOD PHAGOCYTES AT DIFFERENT FORMS OF TUBERCULAR INFLAMMATORY PROCESS OF LUNGS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бердюгина</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Berdyugina</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.б.н., ведущий научный сотрудник, лаборатория диагностических и экспериментальных методов исследования, </p><p>620039, г. Екатеринбург, ул. XXII партсъезда, 50</p></bio><bio xml:lang="en"><p>PhD, MD (Biology), Leading Research Associate, Laboratory of Diagnostic and Experimental Research, </p><p>620039, Yekaterinburg, XXII Partsjezd str., 50</p></bio><email xlink:type="simple">berolga73@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ершова</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Yershova</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>научный сотрудник, лаборатория диагностических и экспериментальных методов исследования, </p><p>620039, г. Екатеринбург, ул. XXII партсъезда, 50</p></bio><bio xml:lang="en"><p>Research Associate, Laboratory of Diagnostic and Experimental Research, </p><p>620039, Yekaterinburg, XXII Partsjezd str., 50</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Уральский научно-исследовательский институт фтизиопульмонологии» Министерства здравоохранения РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ural Research Institute of Phthisiopulmonology, Ministry of Healthcare of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>13</day><month>04</month><year>2016</year></pub-date><volume>18</volume><issue>1</issue><fpage>21</fpage><lpage>32</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Бердюгина О.В., Ершова А.В., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Бердюгина О.В., Ершова А.В.</copyright-holder><copyright-holder xml:lang="en">Berdyugina O.V., Yershova A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/985">https://www.mimmun.ru/mimmun/article/view/985</self-uri><abstract><p>Ведущая роль фагоцитов в противостоянии Mycobacterium tuberculosis установлена. Различные варианты течения туберкулезного воспалительного процесса актуализируют необходимость изучения их функционально-метаболических особенностей у больных с разными формами туберкулеза легких, что явилось целью данного исследования. Обследовано 124 человека, из которых 25 были практически здоровыми людьми, а 99 имели один из трех вариантов туберкулезного воспалительного процесса: 31 – ограниченный специфический – туберкулему, 44 – инфильтративный туберкулез легких, 24 – фиброзно-кавернозный туберкулез легких. Оценивали маркеры активации нейтрофилов и моноцитов (phagotest, bursttest – продукцию супероксид-аниона, CD11b+, CD11c+, HLA-DR-Ag), а также основные показатели клеточного иммунитета (CD45+CD3+, CD45+CD19+, CD45+CD3- CD16+56+). Статистическая обработка проведена в среде «Microsoft Office Excel 2007» и «Statistica for Windows v. 6.1». Установлено выраженное снижение доли моноцитов, способных к генерации супероксид-аниона, которое составляло 10,1% при фиброзно-кавернозном туберкулезе в сравнении с пациентами, имеющими туберкулемы и инфильтративный туберкулез. Также при фиброзно-кавернозном туберкулезе была повышена экспрессия маркеров адгезии CD11b – в сред- нем на 49,0% и CD11с – на 73,5% в сравнении с вышеописанными группами больных. Выявлен факт б льшего снижения поглотительной функции гранулоцитов у больных с активными формами туберкулеза, в сравнении с ограниченными (туберкулемы) вариантами патологического процесса. Фиброзно-кавернозный туберкулез сопровождался повышением абсолютного числа гранулоцитов, вырабатывающих как супероксид-анион, так и экспрессирующих CD11b+ и CD11c+. Выяснено, что снижение количества лимфоцитов у больных с туберкулемами носило относительный характер и соответствовало росту количества гранулоцитов и моноцитов в периферической крови пациентов. Проведенное исследование позволило установить, что каждая форма туберкулезного воспалительного процесса характеризуется индивидуальной «картиной» иммунологических изменений. У больных с туберкулемами отмечается снижение фагоцитарной и функционально-метаболической активности моноцитов, на гранулоцитах увеличивается количество молекул адгезии 11b и 11с, выявляется увеличение числа Т-лимфоцитов, снижение числа NK-клеток. Инфильтративный туберкулез сопровождается ростом популяции моноцитов с повышением на них экспрессии HLA-DR, гранулоциты характеризуются усилением экспрессии молекул адгезии 11b+ и 11с+, число Т-лимфоцитов снижается. При фиброзно-кавернозном туберкулезе наблюдается лейкоцитоз, моноцитоз, гранулоцитоз. Основными функциональными особенностями моноцитов при данной форме туберкулезного воспалительного процесса становится значительное число клеток, экспрессирующих на своей поверхности молекулы адгезии 11b+ и 11с+, функционально-метаболическая активность гранулоцитов, а также популяция клеток, экспрессирующих CD11b+ увеличивается, отмечается рост числа B-клеток.</p></abstract><trans-abstract xml:lang="en"><p>A leading role of phagocytes in prevention of M. tuberculosis infection is well established. Various clinical variants of tubercular inflammatory process necessitate further studies of functional and metabolic features of blood phagocytes in the patients with different forms of lung tuberculosis, being the main goal of this study. We have observed a total of 124 persons including 25 healthy subjects, and 99 patients with tuberculosis who manifested with different types of tubercular inflammatory process, i.e., 31 patients had a limited specific process (tuberculoma); in 44 patients, an infiltrative lung tuberculosis was diagnosed, and 24 patients had fibro-cavernous tuberculosis of lungs. We studied activation markers of neutrophils and monocytes (phagotest, burst-test, CD11b+, CD11c+, HLA-DR-Ag), as well as main indicators of cellular immunity (CD45+CD3+, CD45+CD19+, CD45+CD3- CD16+56+). Statistical evaluation was carried out in the «Microsoft Office Excel 2007» and «Statistica for Windows v. 6.1» environment.</p><p>A considerable decrease in proportion of superoxide anion-producing monocytes was found in 10% of the patients with fibro-cavernous tuberculosis as compared to the patients with tuberculoma and infiltrative tuberculosis. Similarly, the fibro-cavernous tuberculosis was characterized by higher expression of adhesion markers, e.g., CD11b, by 49%, and CD11c, by 73.5%, when compared with the two other groups of patients. A considerable decrease of absorbing granulocyte function was found in the patients with active forms of tuberculosis, as compared with limited clinical forms (tuberculoma). Fibro-cavernous tuberculosis was associated with increased absolute numbers of granulocyte that produce both superoxide anion, and express surface CD11b+ and CD11c+. We have revealed a relative decrease in lymphocyte quantities in the patients from tuberculoma which corresponded to increased granulocyte quantities of granulocytes and monocytes in the patients’ blood. The conducted study allowed us to make a conclusion that each clinical form of tuberculosis id characterized by a specific immunological pattern.</p><p>In the patients with tuberculoma, we have revealed a decrease of phagocytic, functional and metabolic activities of monocytes is noted, along with increased quantities of CD11b+ and CD11c+ adhesion molecules on granulocytes, increased numbers of T-lymphocytes, and decreased amounts of NK-cells. Infiltrative tuberculosis is characterized by increased contents and higher HLA-DR expression of the monocytes, with enhanced expression of CD11b+ and CD11c+ adhesion molecules on the granulocytes, and decreased number of T-lymphocytes. In the fibro-cavernous tuberculosis we observed leukocytosis, monocytosis, granulocytosis. The main functional feature of this clinical form is an increased amount of CD 11b+ and CD 11с+-bearing leukocytes, higher functional and metabolic activity of granulocytes, as well as expansion of CD11b+ expressing cell population and increased numbers of B-cells in peripheral blood.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>моноциты</kwd><kwd>гранулоциты</kwd><kwd>фагоцитоз</kwd><kwd>молекулы адгезии</kwd><kwd>супероксид-анион</kwd><kwd>HLA-DR</kwd><kwd>туберкулез легких</kwd></kwd-group><kwd-group xml:lang="en"><kwd>monocytes</kwd><kwd>granulocytes</kwd><kwd>phagocytosis</kwd><kwd>adhesion molecules</kwd><kwd>superoxide-anion</kwd><kwd>HLA-DR</kwd><kwd>lung tuberculosis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Мордык А.В., Батищева Т.Л., Брюханова Н.С., Пузырева Л.В. Влияние иммунологических нарушений на исход впервые выявленного инфильтративного туберкулеза у социально сохранных пациентов // Инфекция и иммунитет, 2014. Т. 4, №4. С. 353-358.[Mordyk A.V., Batishcheva T.L., Bryukhanova N.S., Puzyreva L.V. Influence of immunological disorders on an outcome for the first time diadnosed infiltrative tuberculosis in socially safe patients. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2014, Vol. 4, no. 4, pp. 353-358. doi: 10.15789/2220-7619-2014-4-353-358 (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Мордык А.В., Батищева Т.Л., Брюханова Н.С., Пузырева Л.В. Влияние иммунологических нарушений на исход впервые выявленного инфильтративного туберкулеза у социально сохранных пациентов // Инфекция и иммунитет, 2014. Т. 4, №4. С. 353-358.[Mordyk A.V., Batishcheva T.L., Bryukhanova N.S., Puzyreva L.V. Influence of immunological disorders on an outcome for the first time diadnosed infiltrative tuberculosis in socially safe patients. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2014, Vol. 4, no. 4, pp. 353-358. doi: 10.15789/2220-7619-2014-4-353-358 (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ameglio F., Casarini M., Capoluongo E., Mattia P., Puglisi G., Giosuè S. Post-treatment changes of six cytokines in active pulmonary tuberculosis: differences between patients with stable or increased fibrosis. Int. J. Tuberc. Lung. Dis., 2005, Vol. 9, no. 1, pp. 98-104.</mixed-citation><mixed-citation xml:lang="en">Ameglio F., Casarini M., Capoluongo E., Mattia P., Puglisi G., Giosuè S. Post-treatment changes of six cytokines in active pulmonary tuberculosis: differences between patients with stable or increased fibrosis. Int. J. Tuberc. Lung. Dis., 2005, Vol. 9, no. 1, pp. 98-104.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ariga H., Harada N. Evolution of IGRA researches. Kekkaku, 2008, Vol. 83, no. 9, pp. 641-652.</mixed-citation><mixed-citation xml:lang="en">Ariga H., Harada N. Evolution of IGRA researches. Kekkaku, 2008, Vol. 83, no. 9, pp. 641-652.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Bell L.C.K., Breen R., Miller R.F., Noursadeghi M., Lipman M. Paradoxical reactions and immune reconstitution inflammatory syndrome in tuberculosis. International J. of Infectious Diseases, 2015, Vol. 32, pp. 39-45.</mixed-citation><mixed-citation xml:lang="en">Bell L.C.K., Breen R., Miller R.F., Noursadeghi M., Lipman M. Paradoxical reactions and immune reconstitution inflammatory syndrome in tuberculosis. International J. of Infectious Diseases, 2015, Vol. 32, pp. 39-45.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Dorhoi A., Kaufmann S.H. Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis. Semin. Immunopathol., 2015, Vol. 5, pp. 1-14.</mixed-citation><mixed-citation xml:lang="en">Dorhoi A., Kaufmann S.H. Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis. Semin. Immunopathol., 2015, Vol. 5, pp. 1-14.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Duque C., Arroyo L., Ortega H., Montufar F., Ortiz B., Rojas M., Barrera L.F. Different responses of human mononuclear phagocyte populations to Mycobacterium tuberculosis. J. Tuberculosis, 2014, Vol. 94, Issue 2, pp. 111-122.</mixed-citation><mixed-citation xml:lang="en">Duque C., Arroyo L., Ortega H., Montufar F., Ortiz B., Rojas M., Barrera L.F. Different responses of human mononuclear phagocyte populations to Mycobacterium tuberculosis. J. Tuberculosis, 2014, Vol. 94, Issue 2, pp. 111-122.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ferraz J.C., Melo F.B.S., Albuquerque M.F.P.M., Montenegro S.M.L., Abath F.G.C. Immune factors and immunoregulation in tuberculosis. Braz. J. Med. Biol. Res., 2006, Vol. 39, no. 11, pp. 1387-1397.</mixed-citation><mixed-citation xml:lang="en">Ferraz J.C., Melo F.B.S., Albuquerque M.F.P.M., Montenegro S.M.L., Abath F.G.C. Immune factors and immunoregulation in tuberculosis. Braz. J. Med. Biol. Res., 2006, Vol. 39, no. 11, pp. 1387-1397.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Flannagan R.S., Cosío G., Grinstein S. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nature Reviews Microbiology, 2009, no. 7, pp. 355-366.</mixed-citation><mixed-citation xml:lang="en">Flannagan R.S., Cosío G., Grinstein S. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nature Reviews Microbiology, 2009, no. 7, pp. 355-366.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Hunter R.L. Pathology of post primary tuberculosis of the lung: an illustrated critical review. Tuberculosis (Edinburgh, Scotland), 2011, Vol. 91, no. 6, pp. 497-509.</mixed-citation><mixed-citation xml:lang="en">Hunter R.L. Pathology of post primary tuberculosis of the lung: an illustrated critical review. Tuberculosis (Edinburgh, Scotland), 2011, Vol. 91, no. 6, pp. 497-509.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Miranda M.S., Breiman A., Allain S., Deknuydt F., Altare F. The tuberculous granuloma: an unsuccessful host defence mechanism providing a safety shelter for the bacteria? Clinical and Developmental Immunology, 2012, Vol. 2012, pp. 1-14.</mixed-citation><mixed-citation xml:lang="en">Miranda M.S., Breiman A., Allain S., Deknuydt F., Altare F. The tuberculous granuloma: an unsuccessful host defence mechanism providing a safety shelter for the bacteria? Clinical and Developmental Immunology, 2012, Vol. 2012, pp. 1-14.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ramachandra L., Smialek J. L., Shank S. S., Convery M., Boom W. H., Harding C. V. Phagosomal processing of Mycobacterium tuberculosis antigen 85b is modulated independently of mycobacterial viability and phagosome maturation. Infection and Immunity, 2005, Vol. 73, no. 2, pp. 1097-1105.</mixed-citation><mixed-citation xml:lang="en">Ramachandra L., Smialek J. L., Shank S. S., Convery M., Boom W. H., Harding C. V. Phagosomal processing of Mycobacterium tuberculosis antigen 85b is modulated independently of mycobacterial viability and phagosome maturation. Infection and Immunity, 2005, Vol. 73, no. 2, pp. 1097-1105.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Sakamoto K. The Pathology of Mycobacterium tuberculosis infection. Veterinary Pathology, 2012, Vol. 49, no. 3, pp. 423-439.</mixed-citation><mixed-citation xml:lang="en">Sakamoto K. The Pathology of Mycobacterium tuberculosis infection. Veterinary Pathology, 2012, Vol. 49, no. 3, pp. 423-439.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Sakharova I.I., Ariél B.M., Skvortsova I.A., Knoring B.E., Vishnevski B.I., Aleshina G.M., Kokriakov V.N. Immunological parameters and mycobacterial biological properties in infiltrative pulmonary tuberculosis. Probl. Tuberk. Bolezn. Legk., 2005, no. 11, pp. 14-18.</mixed-citation><mixed-citation xml:lang="en">Sakharova I.I., Ariél B.M., Skvortsova I.A., Knoring B.E., Vishnevski B.I., Aleshina G.M., Kokriakov V.N. Immunological parameters and mycobacterial biological properties in infiltrative pulmonary tuberculosis. Probl. Tuberk. Bolezn. Legk., 2005, no. 11, pp. 14-18.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Sharma S.K., Mohan A., Sharma A. Challenges in the diagnosis and treatment of miliary tuberculosis. Indian J. Med. Res, 2012, Vol. 135, no. 5, pp.703-730.</mixed-citation><mixed-citation xml:lang="en">Sharma S.K., Mohan A., Sharma A. Challenges in the diagnosis and treatment of miliary tuberculosis. Indian J. Med. Res, 2012, Vol. 135, no. 5, pp.703-730.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Tuberculosis / M. Monir Madkour, ed. Germany: Springer Science &amp; Business Media, 2004. 930 p.</mixed-citation><mixed-citation xml:lang="en">Tuberculosis / M. Monir Madkour, ed. Germany: Springer Science &amp; Business Media, 2004. 930 p.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ulrichs T., Kosmiadi G.A., Jörg S., Pradl L., Titukhina M., Mishenko V., Gushina N., Kaufmann S.H.E. Differential organization of the local immune response in patients with active cavitary tuberculosis or with nonprogressive tuberculoma. J. Infect. Dis., 2005, Vol. 192, no. 1, pp. 89-97.</mixed-citation><mixed-citation xml:lang="en">Ulrichs T., Kosmiadi G.A., Jörg S., Pradl L., Titukhina M., Mishenko V., Gushina N., Kaufmann S.H.E. Differential organization of the local immune response in patients with active cavitary tuberculosis or with nonprogressive tuberculoma. J. Infect. Dis., 2005, Vol. 192, no. 1, pp. 89-97.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Van Crevel R., Ottenhoff T.H.M., Van der Meer J.W.M. Innate Immunity to Mycobacterium tuberculosis. Clin. Microbiol. Rev., 2002, Vol. 15, no. 2, pp. 294-309.</mixed-citation><mixed-citation xml:lang="en">Van Crevel R., Ottenhoff T.H.M., Van der Meer J.W.M. Innate Immunity to Mycobacterium tuberculosis. Clin. Microbiol. Rev., 2002, Vol. 15, no. 2, pp. 294-309.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Vergne I., Chua J., Singh S.B., Deretic V. Cell biology of Mycobacterium tuberculosis phagosome. Annu Rev. Cell Dev. Biol., 2004, Vol. 20, pp. 367-394.</mixed-citation><mixed-citation xml:lang="en">Vergne I., Chua J., Singh S.B., Deretic V. Cell biology of Mycobacterium tuberculosis phagosome. Annu Rev. Cell Dev. Biol., 2004, Vol. 20, pp. 367-394.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Walzl G., Ronacher K., Hanekom W., Scriba T.J., Zumla A. Immunological biomarkers of tuberculosis. Nature Reviews Immunology, 2011, Vol. 11, pp. 343-354.</mixed-citation><mixed-citation xml:lang="en">Walzl G., Ronacher K., Hanekom W., Scriba T.J., Zumla A. Immunological biomarkers of tuberculosis. Nature Reviews Immunology, 2011, Vol. 11, pp. 343-354.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Q, Liu S., Tang Y., Liu Q., Yao Y. MPT64 Protein from Mycobacterium tuberculosis inhibits apoptosis of macrophages through NF-kB-miRNA21-Bcl-2 pathway. J. Plos, 2014, Vol. 9, Issue 7, pp. 1-8.</mixed-citation><mixed-citation xml:lang="en">Wang Q, Liu S., Tang Y., Liu Q., Yao Y. MPT64 Protein from Mycobacterium tuberculosis inhibits apoptosis of macrophages through NF-kB-miRNA21-Bcl-2 pathway. J. Plos, 2014, Vol. 9, Issue 7, pp. 1-8.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
